- (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print (2 cases)
Neuropsychiatric / neuropsychological adverse effect
- (2020): di Mauro G+, Drug Saf Dec, Online ahead of print [REVIEW]
Adverse reactions attributed to entire drug class 'Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor'
Please login to view adverse reactions.
Hypertransaminasemia (hepatic transaminitis) / elevated transaminases
- (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print2%
- (2022): Feng Z+, Front Pharmacol Nov (e-Collection)
- (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print11%
- (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print26%
- (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print5%
Musculoskeletal adverse effects
- (2022): Feng Z+, Front Pharmacol Nov (e-Collection)
Myalgia/Myositis/Myopathy/Myotoxicity
- (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print26%
- (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print4%
